Liraglutide biosimilar (Chenan/Paijin)
利拉鲁肽生物类似药（宸安/派金）
Report date: 2024/12/03 11:21:27
Base Information
Drug NameLiraglutide biosimilar (Chenan/Paijin)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesChongqing Chenan Biopharmaceutical Co LtdChongqing Peg-Bio Biopharm Co Ltd
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A